Precipio Inc. Hits Q2 Revenue Record, Rebounds to Positive EBITDA in Health Care
Precipio’s Q2 report shows record revenue and a return to positive EBITDA, signaling strong growth in oncology diagnostics and biopharma services.
3 minutes to read
PRECIPIO INC